HEIDELBERG, Germania–(BUSINESS WIRE)–NovaTears®, le prime gocce oculari distribuite commercialmente da Novaliq GmbH per il trattamento della secchezza oculare evaporativa (DED), secondo una nuova ricerca hanno dimostrato di migliorare significativamente quattro o cinque parametri associati alla malattia. Le gocce NovaTears hanno inoltre dimostrato di essere sicure, ben tollerate e di non aver modificato né l’acutezza visiva, né la pressione intraoculare (IOP). Il calo dell’indice OSDI (Ocular
The use of topical NSAIDs as well as combination therapy with topical corticosteroids may decrease the odds of patients developing cystoid macular edema after cataract surgery, according to a study.The systematic review and meta-analysis compared rando…
LOS ANGELES–(BUSINESS WIRE)–Two philanthropic gifts, totaling $4 million, have been pledged in support of The Vision Center at Children’s Hospital Los Angeles, an international referral center for children with complex eye diseases. A $2 million gift from the Larry & Celia Moh Foundation to The Vision Center will help establish the A. Linn Murphree Retinoblastoma Program Chair. CHLA ophthalmologist A. Linn Murphree, MD, established the retinoblastoma center at Children’s Hospital Los Ange
FLORENCE, Italy — At the FLOREtina meeting, Donald J. D’Amico, MD, talks about new forms of vitreous cutters, including ultrasonic and laser probes. New advances in vitreous cutter technology aim at improving efficiency, precision and stability in the eye.
(MedPage Today) — All prescribers should be addressed, not just outliers, expert says
(MedPage Today) — This year’s BMJ Christmas issue recognizes a medically neglected issue: the undead